AMUNDI – Alnylam Pharmaceuticals, Inc. Transaction History
AMUNDI portfolio value:
$240.40M
portfolio value
AMUNDI quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +31.92% | 289.37K shares | 114.80M | $200.16 | 1.19M |
| Q2 2022 | share | Increase | +3.61% | 31.58K shares | -16.36M | $145.85 | 906.53K |
| Q1 2022 | share | Increase | +244.12% | 620.69K shares | 104.32M | $163.29 | 874.95K |
| Q4 2021 | share | Decrease | -2.35% | -6.11K shares | -11.53M | $171.03 | 254.25K |
| Q3 2021 | share | Increase | +21.49% | 46.06K shares | 12.83M | $188.81 | 260.36K |
| Q2 2021 | share | Increase | 0.00% | 214.30K shares | 36.32M | $169.52 | 214.30K |